The site of the Media Sphera Publishers contains materials intended solely for healthcare professionals.
By closing this message, you confirm that you are a certified medical professional or a student of a medical educational institution.

Skvortsova V.I.

Rossiĭskiĭ gosudarstvennyĭ meditsinskiĭ universitet;
NII tserebrovaskuliarnoĭ patologii i insul'ta, Moskva

Kontsevoĭ V.A.

Nauchnyĭ tsentr psikhicheskogo zdorov'ia RAMN, Moskva

Savina M.A.

Nauchnyĭ tsentr psikhicheskogo zdorov'ia RAMN, Moskva

Petrova E.A.

FGBU "NII onkologii im. N.N. Petrova" Minzdrava Rossii, Sankt-Peterburg

Serpukhovitina I.A.

Nauchnyĭ tsentr psikhicheskogo zdorov'ia RAMN, Moskva

Shanina T.V.

NII tserebrovaskuliarnoĭ patologii i insul'ta Rossiĭskogo gosudarstvennogo meditsinskogo universiteta

Poststroke generalized anxiety disorder: correlations with depression, risk factors, the influence on the restoration of lost functions, pathogenesis, treatment

Authors:

Skvortsova V.I., Kontsevoĭ V.A., Savina M.A., Petrova E.A., Serpukhovitina I.A., Shanina T.V.

More about the authors

Read: 1831 times


To cite this article:

Skvortsova VI, Kontsevoĭ VA, Savina MA, Petrova EA, Serpukhovitina IA, Shanina TV. Poststroke generalized anxiety disorder: correlations with depression, risk factors, the influence on the restoration of lost functions, pathogenesis, treatment. S.S. Korsakov Journal of Neurology and Psychiatry. 2010;110(10):4‑7. (In Russ.)

Recommended articles:
Factors dete­rmining postoperative mortality in patients with hype­rtensive intracerebral hema­tomas. S.S. Korsakov Journal of Neurology and Psychiatry. 2025;(3-2):35-43
Asso­ciations of subclinical athe­rosclerosis with soma­tic diseases. Russian Journal of Preventive Medi­cine. 2025;(2):109-113
Risk factors of inte­rnal caro­tid artery tortuosity. Russian Journal of Cardiology and Cardiovascular Surgery. 2025;(2):150-155
Epidemiology of M. geni­talium infe­ction. What is known?. Russian Journal of Clinical Dermatology and Vene­reology. 2025;(2):143-152
Premature birth and obesity: epidemiology, pathogenesis and obstetric tactics. Russian Bulletin of Obstetrician-Gynecologist. 2025;(2):29-34

References:

  1. Gekht A.B., Bogolepova A.N., Sorokina I.B.Depressiya posle insul'ta: opyt primeneniya tsipramila. Zhurn nevrol i psikhiat 2002; 5: 36-39.
  2. Dmitrieva G.B., Drozdov A.Z., Kogan B.M.Perifericheskie pokazateli metabolizma serotonina pri psikhicheskikh rasstroistvakh. Ros psikh zhurn 2000; 4: 52-56.
  3. Skvortsova V.I., Petrova E.A., Brusov O.S. i dr.Patogeneticheskie osobennosti razvitiya postinsul'tnykh affektivnykh rasstroistv. Zhurn nevrol i psikhiat 2010; 7: 35-40.
  4. Savina M.A., Serpukhovitina M.A.Klinika postinsul'tnogo generalizovannogo trevozhnogo rasstroistva. Psikhicheskie rasstroistva v obshchei meditsine 2009; 2: 4-9.
  5. Tkachenko A.A.Parafilii i anomal'noe seksual'noe povedenie: Dis. … d-ra med. nauk. M 1994; 387.
  6. Yusupova I.U., Kekelidze Z.I., Drozdov A.Z. i dr.Uroven' GVK i
  7. Andersen G., Vestergaard K., Lauritzen L.Effective treatment of poststroke depression with the selective serotonin reuptake inhibitor citalopram. Stroke 1994; 25: 6: 1099-1104.
  8. Astroem M.Generalized anxiety disorder in stroke patients: a 3-year longitudinal study. Stroke 1996; 27: 270-275.
  9. Bertz R.J., Kroboth P.D., Kroboth F.J. et al.Alprazolam in young and elderly men: sensitivity and tolerance to psychomotor, sedative and memory effects. J Pharmacol Exp Ther 1997; 281: 1317-1329.
  10. Burwill P.W., Johnson G.A., Jamrozik K.D. et al.Anxiety disorders after stroke: results from the Perth community stroke study. Br J Psychiat 1995; 166: 3: 328-332.
  11. Castillo C.S., Starkstein S.E., Fedoroff J.P. et al.Generalized anxiety disorder following stroke. J Nerv Mental Dis 1993; 181: 100-106.
  12. Castillo C.S., Schulz S.K., Robinson R.G.Clinical correlates of early onset and late onset posstroke generalized anxiety. Am J Psychiat 1995; 152: 1174-1179.
  13. Celada P., Sarrias M.J., Artigas F.Serotonin and 5-hydroxyindoleacetic acid in plasma. Potential use as peripheral measures of MAO-A activity. J Neural Transm 1990; 32: Suppl: 149-154.
  14. Egan M., Moride Y., Wolfson C., Monette J.Long-term continuous use of benzodiazepines by older adults in Quebec: prevalence, incidence and risk factors. J Am Geriatr Soc 2000; 48: 811-816.
  15. Erfurth A., Loew M., Wendler G., Floreanu A.Treatment of depressive disorders in neurological rehabilitation: effect of paroxetine. Psychiatrische Praxis 2001; 28: 43-44.
  16. Gainotti G.Emotional behavior and hemispheric side of the brain. Cortex 1972; 8: 41-55.
  17. Graeff F.G., Guimarães F.S. et al.Role of 5-HT in stress, anxiety, and depression. Pharmacol Biochem Behav 1996; 54: 1: 129-141.
  18. Graeff F.G., Viana M.B., Mora P.O.Dual role of 5-HT in defense and anxiety. Neurosci Biobehav Rev 1997; 21: 6: 791-799.
  19. Gur R.C., Gur R.E., Resnick S.M. et al.The effect of anxiety on cortical cerebral blood flow and metabolism. J Cereb Blood Flow Metab 1987; 7: 173-177.
  20. Feeney D.M., Baron J.C.Diashisis. Stroke 1986; 17: 817-830.
  21. Kimura M., Tateno A., Robinson R.G.Treatment of poststroke generalized anxiety disorder comorbid with poststroke depression: merged analysis of nortriptyline trials. Am J Geriat Psychiat 2003; 11: 3: 320-327.
  22. Kroeze W.K., Roth B.L.The molecular biology of serotonin receptors: therapeutic implications for the interface of mood and psychosis. Biol Psychiat 1998; 44: 11: 1128-1142.
  23. Leppavuori A., Pojasvaara T., Vataja R. et al.Generalized anxiety disorder three to four month after ischemic stroke. Cerebrovascular Desease 2003; 16: 3: 257-264.
  24. Mayberg H.S., Robinson R.G., Wong D.E. et al.PET imaging of cortical S2-serotonin receptors after stroke: lateraliyed changes and relationship to depression. Am J Psychiat 1988; 145: 937-943.
  25. Miyai I., Reding M.J.Effects of antidepressants on functional recovery following stroke: A double-blind study. J Neurol Rehabilitation 1998; 12: 1: 5-13.
  26. Overstreet D.H., Commissaris R.C. et al.Involvement of 5-HT1A receptors in animal tests of anxiety and depression: Evidence from genetic models. Stress 2003; 6: 2: 101-110.
  27. Paul S.M.Anxiety and depression: a common neurobiological substrate J Clin Psychiat 1988; 49: Suppl 10: 13-16.
  28. Pomara N., Tun H., DaSilva D. et al.The acute and chronic performance effects of alprozalam and lorazepam in the elderly: relationship to duration of treatment and seld-rated sedation. Psychopharmacol Bull 1998; 34: 139-153.
  29. Raffaele R., Rampello L., Vecchio I.et al.Trazodone therapy of the post-stroke depression. Arch Gerontol and Geriat 1996; 23: Suppl 5: 217-220.
  30. Rampello L., Chiechio S., Nicoletti G. et al.Prediction of the response to citalopram and reboxetine in post-stroke depressed patients. Psychopharmacology (Berl.) 2004; 173: 1-2: 73-78.
  31. Rasmussen A., Lunde M., Poulsen D.L. et al.A Double-blind, placebo-controlled study of sertraline in the prevention of depression in stroke. Patients Psychosomatics 2003; 44: 3: 216-221.
  32. Redding J.J., Orto L.A., Winter S.W. et al.Antidepressant therapy after stroke: a double-blind trial. Arch Neurol 1986; 43: 763-765.
  33. Robinson R.G.The clinical neuropsychiatry of stroke. Cognitive, behavioral and emotional disorders following vascular brain injury. Second edition. Cambrige University Press 2006; 317-354.
  34. Robinson R.G., Schultz S.K., Castillo S. et al.Nortriptyline versus fluoxetine in treatment of depression and in short term recovery after stroke: a placebo controlled, double-blind study. Am J Psychiat 2000; 157: 351-359.
  35. Rudolph R.L., Entsuah R., Chitra R.A meta-analysis of the effects of venlafaxine on anxiety associated with depression. J Clin Psychopharmacol 1998; 18: 2: 136-144.
  36. Ryynamen O.P., Kivela S.L., Honkanen R. et al.Medications and chronic deseases as risk factors of falling injuries in the elderly. Scand J Sjc Med 1993; 1: 264-271.
  37. Shima S.The efficacy of antidepressants in post-stroke depression. Keio J Med 1997; 46: 1: 25-26.
  38. Shimoda K., Robinson R.G.Effect of anxiety disorder in impairment and recovery from stroke. J Neuropsychiat Clin Neurosci 1998; 10: 34-40.
  39. Siepmann M., Joraschky P.Modelling anxiety in humans for drug development. Curr Neuropharmacol 2007; 5: 1: 65-72.
  40. Spaletta G., Caltagirone C.Sertraline treatment of post-stroke major depression: an open study in patients with moderate to severe symptoms. Funct Neurol 2003; 18: 4: 227-232.
  41. Stahl S.M.Mixed depression and anxiety: serotonin 1A receptors as a common pharmacologic link. J Clin Psychiat 1997; 58: Suppl 8: 20-26.
  42. Starkstein S.E., Cohen B.S., Fedoroff P. et al.Relationship between anxiety states and depressive illness. Arch Gen Psychiat 1972; 121: 175-181.
  43. Wong D.T., Bymaster F.P.Dual serotonin and noradrenaline uptake inhibitor class of antidepressants potential for greater efficacy or just hype Prog Drug Res 2002; 58: 169-222.

Email Confirmation

An email was sent to test@gmail.com with a confirmation link. Follow the link from the letter to complete the registration on the site.

Email Confirmation

We use cооkies to improve the performance of the site. By staying on our site, you agree to the terms of use of cооkies. To view our Privacy and Cookie Policy, please. click here.